Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Intangibles (2021 - 2026)

Zymeworks (ZYME) posted Intangibles of $1.2 million for Q1 2026, down 13.04% sequentially from $1.3 million in Q4 2025, and down 65.08% YoY from $3.4 million in Q1 2025.

Analysis

Zymeworks (ZYME) Intangibles (2021 - 2026) Analysis & Trends

Zymeworks has reported Intangibles for 6 years, with the latest figure at $1.2 million in Q1 2026.

  • Quarterly Intangibles fell 65.08% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 65.08% YoY) and the FY2025 annual result came in at $1.3 million, down 70.5% from the prior year.
  • Intangibles slipped to $1.2 million in Q1 2026 per ZYME's latest filing, from $1.3 million in the prior quarter.
  • Over five years, Intangibles peaked at $17.6 million in Q4 2022 and troughed at $341000.0 in Q2 2024.
  • A 5-year average of $6.4 million and a median of $6.4 million in 2024 frame the typical range for Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Intangibles sank 95.39% in 2024, then jumped 499.71% in 2025.
  • Over 5 years, Intangibles stood at $17.6 million in 2022, then sank by 56.57% to $7.7 million in 2023, then sank by 40.23% to $4.6 million in 2024, then plunged by 70.5% to $1.3 million in 2025, then declined by 13.04% to $1.2 million in 2026.
  • According to Business Quant data, Intangibles over the past three periods registered $1.2 million, $1.3 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 412.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 266.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 63.28 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 60.96 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 93.49 Mn
10 Zymeworks 2.13 Bn 1.86 Bn - 998,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 998,000.00
Mar 31, 2026 1.17 Mn
Dec 31, 2025 1.35 Mn
Sep 30, 2025 1.40 Mn
Jun 30, 2025 2.05 Mn
Mar 31, 2025 3.36 Mn
Dec 31, 2024 4.58 Mn
Sep 30, 2024 6.41 Mn
Jun 30, 2024 7.11 Mn
Mar 31, 2024 17.63 Mn
Dec 31, 2023 17.63 Mn
Sep 30, 2023 17.63 Mn
Jun 30, 2023 17.63 Mn
Mar 31, 2023 17.63 Mn
Dec 31, 2022 17.63 Mn
Sep 30, 2022 17.63 Mn
Dec 31, 2021 17.63 Mn